FOIA Documents Reveal How 2 FDA Vaccine Oversight Staffers Sought Employment With Moderna

Documents obtained via the Freedom of Information Act reveal that two former FDA officials who oversaw the approval of mRNA COVID-19 vaccines subsequently moved to executive roles at Moderna. This transition has raised significant concerns about potential conflicts of interest and the integrity of the regulatory approval process. The revelations highlight a troubling pattern where regulators, who are tasked with ensuring public safety, transition directly into the private companies they once supervised, creating perceptions of a "cozy" relationship between government oversight and pharmaceutical industry interests. While the FDA enforces a recusal protocol requiring staff to disengage from matters affecting prospective employers, experts argue this measure is insufficient to guarantee impartiality. Critics note that even with proper recusal, former employees retain valuable institutional knowledge and personal networks, allowing them to influence agency decisions "behind the scenes." This loophole means that the appearance of independence is maintained, but the actual ability to shape regulatory outcomes in favor of specific corporate interests remains, undermining the rigor of the oversight process. This situation is critical to open data and government transparency because it exposes the hidden mechanisms of the "revolving door" between public service and private industry. Without comprehensive disclosure of the specific interactions and decision-making influences exerted by former regulators, the public cannot fully assess the validity of vaccine approvals. The case underscores the urgent need for stricter cooling-off periods and greater transparency in regulatory movements to ensure that agencies serve the public interest rather than becoming co-opted by the private sector they regulate.

Source: theepochtimes.com
Published on 2024-04-05

Elevó marzo la confianza del consumidor: Inegi »

Open Data

Related news